Oncology Med Announces Rapid Increase in IMRT Treatment Planning and Expects a 100% Increase in Second Quarter From Previous Quarter
Monday June 18, 2007 10:30 am ET
PITTSBURGH, PA--(MARKET WIRE)--Jun 18, 2007 -- Oncology Med, Inc. (Other OTC:ONCO.PK - News) announces that it expects its Intensity Modulated Radiation Treatment (IMRT) planning results for the second quarter will be more than double the number performed in the first quarter, 2007. The Oncology Med Treatment Planning center, Pittsburgh, PA, results will represent the second consecutive time that it has doubled its IMRT planning totals.
ADVERTISEMENT
Dr. William J. Walker, chairman of Oncology Med, Inc., stated, "I am extremely pleased with our IMRT treatment planning numbers for the second quarter, 2007. We are accelerating our planning numbers at a rapid pace and have achieved a substantial increase over the numbers performed for last year."
About Oncology Med, Inc.
Oncology Med is a public company engaged in the fulfillment of services related to the treatment of various cancers. It currently provides analysis and design of radiation treatment plans in order for radiation oncologists to administer radiation plans to cancer patients. Current services facilitate radiation treatment programs ranging from external beam radiation to more advanced radiation treatment technologies.
More information about Oncology Med, Inc. can be found at www.oncologymed.com.
NOTE: This press release may contain "forward-looking statements.'' In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "could," "expects," "plans," "intends," "anticipates," "believes," "estimates," "predicts," "potential," "continue" or the negative of such terms and other comparable terminology. These forward-looking statements include, without limitation, statements about our market opportunity, our strategies, competition, expected activities and expenditures as we pursue our business plan, and the adequacy of our available cash resources. Although we believe that the expectations reflected in any forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Actual results may differ materially from the predictions discussed in these forward-looking statements. Changes in the circumstances upon which we base our predictions and/or forward-looking statements could materially affect our actual results.
Contact:
For information, please contact:
Mr. Trevor Bentley
Investor Communications
Bentley Communications
1-888-818-8738
Email Contact
--------------------------------------------------------------------------------
Source: Oncology Med
AI
Market Data 
Markets 
